Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

Following the success of our previous roundtables, during which research leaders exchanged ideas on data issues and how they are overcoming them, this intimate session (limited to 6–8 participants) ...